Literature DB >> 29192658

Selective Adenylyl Cyclase Type 1 Inhibitors as Potential Opioid Alternatives For Chronic Pain.

Val J Watts1.   

Abstract

Entities:  

Year:  2018        PMID： 29192658      PMCID： PMC5719099          DOI： 10.1038/npp.2017.190

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  7 in total

Review 1.  Targeting neuronal adenylyl cyclase for the treatment of chronic pain.

Authors:  Min Zhuo
Journal:  Drug Discov Today       Date:  2012-01-26       Impact factor: 7.851

2.  Identification of an adenylyl cyclase inhibitor for treating neuropathic and inflammatory pain.

Authors:  Hansen Wang; Hui Xu; Long-Jun Wu; Susan S Kim; Tao Chen; Kohei Koga; Giannina Descalzi; Bo Gong; Kunjumon I Vadakkan; Xuehan Zhang; Bong-Kiun Kaang; Min Zhuo
Journal:  Sci Transl Med       Date:  2011-01-12       Impact factor: 17.956

Review 3.  Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies.

Authors:  Nora D Volkow; A Thomas McLellan
Journal:  N Engl J Med       Date:  2016-03-31       Impact factor: 91.245

4.  The economic costs of pain in the United States.

Authors:  Darrell J Gaskin; Patrick Richard
Journal:  J Pain       Date:  2012-05-16       Impact factor: 5.820

5.  Re-energizing the Development of Pain Therapeutics in Light of the Opioid Epidemic.

Authors:  Phil Skolnick; Nora D Volkow
Journal:  Neuron       Date:  2016-10-19       Impact factor: 17.173

6.  Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties.

Authors:  Tarsis F Brust; Doungkamol Alongkronrusmee; Monica Soto-Velasquez; Tanya A Baldwin; Zhishi Ye; Mingji Dai; Carmen W Dessauer; Richard M van Rijn; Val J Watts
Journal:  Sci Signal       Date:  2017-02-21       Impact factor: 8.192

Review 7.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468
  7 in total
  2 in total

1.  Optimization of a 1,3,4-oxadiazole series for inhibition of Ca2+/calmodulin-stimulated activity of adenylyl cyclases 1 and 8 for the treatment of chronic pain.

Authors:  Jatinder Kaur; Monica Soto-Velasquez; Zhong Ding; Ahmadreza Ghanbarpour; Markus A Lill; Richard M van Rijn; Val J Watts; Daniel P Flaherty
Journal:  Eur J Med Chem       Date:  2018-11-16       Impact factor: 6.514

2.  Acyclic nucleoside phosphonates with 2-aminothiazole base as inhibitors of bacterial and mammalian adenylate cyclases.

Authors:  Petra Břehová; Ema Chaloupecká; Michal Česnek; Jan Skácel; Martin Dračínský; Eva Tloušťová; Helena Mertlíková-Kaiserová; Monica P Soto-Velasquez; Val J Watts; Zlatko Janeba
Journal:  Eur J Med Chem       Date:  2021-05-28       Impact factor: 7.088
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.